Basel Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Basel Medical Group
BMGL Stock   0.63  0.02  3.28%   
Basel Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Basel Medical's valuation are provided below:
Gross Profit
3.2 M
Profit Margin
(1.00)
Market Capitalization
11.5 M
Enterprise Value Revenue
1.3201
Revenue
12.1 M
There are over one hundred nineteen available fundamental signals for Basel Medical Group, which can be analyzed over time and compared to other ratios. We recommend to validate Basel Medical's prevailing fundamental drivers against the all of the trends between 2010 and 2026.

Basel Medical Total Revenue

11.48 Million

Check Basel Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Basel Medical's main balance sheet or income statement drivers, such as Interest Income of 125.1 K, Depreciation And Amortization of 781.8 K or Interest Expense of 187.9 K, as well as many indicators such as Price To Sales Ratio of 8.98, Dividend Yield of 0.0 or PTB Ratio of 24.43. Basel financial statements analysis is a perfect complement when working with Basel Medical Valuation or Volatility modules.
  
Build AI portfolio with Basel Stock
Check out the analysis of Basel Medical Correlation against competitors.

Basel Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets18 M19.4 M16.9 M
Slightly volatile
Short and Long Term Debt Total5 M3.1 M8.5 M
Slightly volatile
Other Current Liabilities7.5 M7.1 M2.7 M
Slightly volatile
Total Current Liabilities8.7 M12.3 M7.7 M
Slightly volatile
Total Stockholder Equity5.9 M5.6 M4.3 M
Slightly volatile
Property Plant And Equipment Net4.2 M4 M1.6 M
Slightly volatile
Net Debt376.5 K396.4 K6.6 M
Slightly volatile
Accounts Payable1.5 M2.4 M1.3 M
Slightly volatile
Cash2.1 M3.4 M1.8 M
Slightly volatile
Non Current Assets Total4.5 M4.3 M1.6 M
Slightly volatile
Long Term Debt2.7 M1.4 M4.4 M
Slightly volatile
Cash And Short Term Investments2.1 M3.4 M1.8 M
Slightly volatile
Net Receivables2.1 M2.2 M11.7 M
Slightly volatile
Common Stock Shares Outstanding20.6 M21.6 M19 M
Slightly volatile
Liabilities And Stockholders Equity18 M19.4 M16.9 M
Slightly volatile
Non Current Liabilities Total1.1 M1.2 M4.7 M
Slightly volatile
Capital Lease Obligations4.1 M3.9 M1.6 M
Slightly volatile
Inventory454.4 K432.7 K133.4 K
Slightly volatile
Other Current Assets8.8 M8.4 M1.6 M
Slightly volatile
Total Liabilities8.8 M10.8 M12.2 M
Slightly volatile
Net Invested Capital8.3 M4.4 M11.4 M
Slightly volatile
Property Plant And Equipment Gross5.9 M11.5 M4.8 M
Slightly volatile
Short and Long Term Debt52.5 K55.2 K2.9 M
Slightly volatile
Total Current Assets11.9 M11.8 M15 M
Slightly volatile
Capital Stock41.3 M39.3 M8.2 M
Slightly volatile
Net Working Capital2.1 M2.2 M7.4 M
Slightly volatile
Short Term Debt2.6 M1.9 M3.7 M
Slightly volatile
Common Stock41.3 M39.3 M8.2 M
Slightly volatile

Basel Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization781.8 K1.4 M665.8 K
Slightly volatile
Interest Expense187.9 K183.6 K284.7 K
Slightly volatile
Selling General Administrative4.8 M7.5 M4.4 M
Slightly volatile
Total Revenue11.5 M13 M10.8 M
Slightly volatile
Gross Profit8.9 M10.1 M8.5 M
Pretty Stable
Other Operating Expenses10.2 M15.5 M9 M
Slightly volatile
Cost Of Revenue2.6 M2.9 M2.3 M
Slightly volatile
Total Operating Expenses7.7 M12.6 M6.7 M
Slightly volatile
Reconciled Depreciation781.8 K1.4 M665.8 K
Slightly volatile
Minority Interest401451492
Slightly volatile

Basel Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow3.3 M1.8 M8.9 M
Slightly volatile
Depreciation781.8 K1.4 M665.8 K
Slightly volatile
Capital Expenditures31.5 K49.3 K71.3 K
Slightly volatile
End Period Cash Flow2.1 M3.4 M1.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio8.9810.110.7853
Slightly volatile
PTB Ratio24.4317.1627.4403
Slightly volatile
Days Sales Outstanding87.8892.51407
Slightly volatile
Book Value Per Share0.240.360.2395
Slightly volatile
Free Cash Flow Yield0.02520.02550.0234
Pretty Stable
Operating Cash Flow Per Share0.150.13380.1467
Slightly volatile
Average Payables1 M1.3 M1.3 M
Pretty Stable
Capex To Depreciation0.06220.05330.1195
Slightly volatile
PB Ratio24.4317.1627.4403
Slightly volatile
EV To Sales0.04250.04479.6289
Slightly volatile
Free Cash Flow Per Share0.150.13340.1433
Pretty Stable
Inventory Turnover7.337.7226.596
Slightly volatile
Net Income Per Share0.080.09950.1036
Slightly volatile
Days Of Inventory On Hand51.3848.9318.9125
Slightly volatile
Payables Turnover2.071.391.9531
Slightly volatile
Sales General And Administrative To Revenue0.330.520.3929
Slightly volatile
Average Inventory103.9 K201.7 K98.9 K
Slightly volatile
Capex To Revenue0.0040.00560.0068
Slightly volatile
Cash Per Share0.06730.09370.0844
Pretty Stable
POCF Ratio34.5840.4741.4876
Very volatile
PFCF Ratio35.0140.642.5002
Slightly volatile
Days Payables Outstanding169273193
Slightly volatile
Income Quality0.380.41.0254
Slightly volatile
PE Ratio64.5562.658.8717
Pretty Stable
Earnings Yield0.01370.01650.0169
Slightly volatile
Current Ratio2.191.412.0886
Slightly volatile
Tangible Book Value Per Share0.240.360.2395
Slightly volatile
Receivables Turnover4.294.081.3915
Slightly volatile
Shareholders Equity Per Share0.240.360.2395
Slightly volatile
Debt To Equity1.460.812.2197
Slightly volatile
Capex Per Share5.0E-45.0E-40.0035
Slightly volatile
Average Receivables11.2 M8.6 M12.2 M
Slightly volatile
Revenue Per Share0.590.620.5659
Very volatile
Interest Debt Per Share0.440.270.4875
Slightly volatile
Debt To Assets0.420.230.5186
Slightly volatile
Graham Number0.660.90.7396
Slightly volatile
Price Earnings Ratio64.5562.658.8717
Pretty Stable
Operating Cycle147155427
Slightly volatile
Price Book Value Ratio24.4317.1627.4403
Slightly volatile
Days Of Payables Outstanding169273193
Slightly volatile
Price To Operating Cash Flows Ratio34.5840.4741.4876
Very volatile
Price To Free Cash Flows Ratio35.0140.642.5002
Slightly volatile
Ebt Per Ebit5.415.161.7666
Slightly volatile
Effective Tax Rate0.03650.03840.1449
Slightly volatile
Company Equity Multiplier3.563.994.1493
Slightly volatile
Long Term Debt To Capitalization0.190.20.4816
Slightly volatile
Total Debt To Capitalization0.570.470.6573
Slightly volatile
Debt Equity Ratio1.460.812.2197
Slightly volatile
Quick Ratio2.171.372.0747
Slightly volatile
Net Income Per E B T0.70.870.8342
Very volatile
Cash Ratio0.190.250.2228
Slightly volatile
Days Of Inventory Outstanding51.3848.9318.9125
Slightly volatile
Days Of Sales Outstanding87.8892.51407
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.790.910.9604
Slightly volatile
Price To Book Ratio24.4317.1627.4403
Slightly volatile
Fixed Asset Turnover2.82.9518.1056
Pretty Stable
Price Cash Flow Ratio34.5840.4741.4876
Very volatile
Debt Ratio0.420.230.5186
Slightly volatile
Price Sales Ratio8.9810.110.7853
Slightly volatile
Asset Turnover0.510.60.6247
Slightly volatile
Gross Profit Margin0.860.890.8005
Slightly volatile
Price Fair Value24.4317.1627.4403
Slightly volatile

Basel Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap125.5 M129.5 M116.5 M
Slightly volatile
Enterprise Value133.5 M136.4 M124.5 M
Pretty Stable

Basel Fundamental Market Drivers

About Basel Medical Financial Statements

Basel Medical investors utilize fundamental indicators, such as revenue or net income, to predict how Basel Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue13 M11.5 M
Cost Of Revenue2.9 M2.6 M
Sales General And Administrative To Revenue 0.52  0.33 
Revenue Per Share 0.62  0.59 
Ebit Per Revenue(0.22)(0.21)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Basel Medical Group is a strong investment it is important to analyze Basel Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Basel Medical's future performance. For an informed investment choice regarding Basel Stock, refer to the following important reports:
How To Invest In Basel
Details
Is Basel Stock a good investment?
Details
What is Basel Medical's Net Worth?
Details
Largest Health Care Providers & Services Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Basel Medical Correlation against competitors.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Basel Medical. Projected growth potential of Basel fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Basel Medical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.51)
Revenue Per Share
0.644
Quarterly Revenue Growth
0.322
Return On Assets
(0.05)
Return On Equity
(1.95)
Investors evaluate Basel Medical Group using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Basel Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Basel Medical's market price to deviate significantly from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
It's important to distinguish between Basel Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Basel Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Basel Medical's market price signifies the transaction level at which participants voluntarily complete trades.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY